NeuroRehab Team
Thursday, July 30th, 2026
Two of the most common complications affecting the limbs after stroke are spasticity and contracture. They are frequently discussed together, often confused with each other, and sometimes incorrectly treated as the same condition. But they are fundamentally different problems with different causes, different treatment approaches, and very different implications for recovery.
Understanding the difference between spasticity and contracture is not just academic. It directly affects the decisions you and your rehabilitation team make about treatment. Treating contracture as if it were spasticity, or missing the transition from one to the other, can result in months of effort directed at the wrong target.
This guide explains what each condition is, how they relate to each other, how to tell them apart, and what the most effective management approaches are for each.
Spasticity is a neurological condition. It is caused by damage to the upper motor neuron pathways in the brain or spinal cord that normally regulate and inhibit muscle activity. When these pathways are disrupted by a stroke, the muscles they control lose their normal inhibitory input and become overactive.
The result is abnormally increased muscle tone, involuntary muscle contractions, and exaggerated stretch reflexes. The affected muscles resist being stretched, particularly when that stretch is applied quickly. This velocity-dependent resistance, where faster movement meets greater resistance, is the defining clinical feature of spasticity and what distinguishes it from other forms of stiffness.
Spasticity is a neurological problem. The muscles themselves are structurally normal in pure spasticity. The abnormality lies in the signals the nervous system is sending to them. This is a critical point because it means that treatments targeting the nervous system, such as botulinum toxin injections, oral medications, and electrical stimulation, can directly address the underlying problem.
In the upper limb after stroke, spasticity most commonly affects the shoulder adductors and internal rotators, the elbow flexors, the forearm pronators, and the wrist and finger flexors. This produces the characteristic posture of a bent elbow, a pronated forearm, a flexed wrist, and a clenched fist. In the lower limb, the calf muscles and toe flexors are most commonly affected.
Contracture is a structural condition. Unlike spasticity, which is a problem with the signals the nervous system sends to the muscles, contracture is a physical shortening and stiffening of the muscles, tendons, ligaments, joint capsules, and other soft tissues around a joint.
When a limb is held in a shortened position for a prolonged period, the soft tissues adapt to that position by shortening. Muscle fibres are lost and replaced by fibrous connective tissue. The tendons and joint capsule tighten. Over time, these structural changes become fixed, meaning the joint can no longer move through its full range of motion regardless of what the nervous system is doing.
This is the critical distinction. In spasticity, the resistance to movement comes from the nervous system driving excessive muscle activity. If you could remove that neural drive, the muscle would relax and the joint could move freely. In contracture, the resistance to movement comes from the physical structure of the shortened tissues. Even if the nervous system were completely silent, the joint still could not move fully because the tissues have become too short and too stiff.
Contracture does not have a velocity-dependent quality. The stiffness is present regardless of the speed of movement. This is one of the ways to distinguish it from spasticity on examination.
Spasticity and contracture are connected in a very important way: unmanaged spasticity is the most common cause of contracture after stroke.
When spasticity holds a limb in a shortened, flexed position for days, weeks, and months, the soft tissues begin to adapt to that position. The muscle fibres in the shortened position gradually lose sarcomeres, the structural units that allow muscles to lengthen. Collagen is deposited in the muscle and tendon, making the tissue stiffer and less extensible. The joint capsule tightens around the restricted range of motion.
This process happens gradually and insidiously. In the early stages it is reversible with consistent stretching and positioning. In the later stages, when significant structural changes have occurred, it becomes increasingly difficult and eventually impossible to reverse with conservative treatment alone.
This is why preventing contracture by managing spasticity early is so much more effective than trying to treat established contracture later. Once contracture has developed, the treatment options become more limited, more invasive, and less likely to fully restore range of motion.
The timeline for contracture development varies but structural changes can begin within weeks of a limb being held in a shortened position. Research suggests that as little as one to two weeks of immobilisation in a shortened position can begin to produce measurable soft tissue changes. This is why positioning and stretching should begin in the acute phase, even before spasticity has fully developed.
For survivors and caregivers, the most practical way to distinguish spasticity from contracture is to observe two things: the velocity-dependence of the resistance and what happens when the limb is moved.
Velocity-dependence. Move the affected joint slowly and then quickly. Spasticity produces greater resistance with faster movement. Contracture produces the same degree of resistance regardless of speed because it is a structural, not a neurological, problem.
End-range resistance. In spasticity, resistance increases as the muscle is stretched but may release at the end of range in a catch-and-release pattern known as the clasp-knife response. In contracture, there is a firm, unyielding end-feel that does not release. The joint simply will not go further regardless of how slowly or gently you move it.
Response to heat or relaxation. Spasticity often reduces temporarily with warmth, relaxation, or a comfortable position. Contracture is not affected by relaxation because the limitation is structural rather than neurological.
Response to botulinum toxin. If a joint has limited range of motion primarily due to spasticity, botulinum toxin injection into the spastic muscle will produce a meaningful improvement in range of motion. If contracture has developed, botulinum toxin may reduce the neural component of stiffness but the structural shortening will remain, and range of motion improvement will be limited.
| Feature | Spasticity | Contracture |
|---|---|---|
| Cause | Neurological: damage to upper motor neuron pathways | Structural: physical shortening of soft tissues |
| Velocity-dependent? | Yes: worse with faster movement | No: same resistance at any speed |
| Reversible? | Yes with appropriate neurological treatment | Partially: early contracture responds to stretching; established contracture may require surgery |
| Response to relaxation | Improves with warmth and relaxation | Not affected by relaxation |
| Response to botulinum toxin | Significant improvement in tone and range | Limited improvement if structural changes dominate |
| End-feel on movement | Springy or catch-and-release quality | Firm, unyielding, hard stop |
| Primary treatment | Stretching, electrical stimulation, botulinum toxin, oral medications | Prolonged stretching, splinting, serial casting, surgery in severe cases |
Yes, and this is extremely common. Many stroke survivors have a mixed picture where both spasticity and contracture are contributing to the stiffness and limited range of motion in the affected limb. This is particularly common in survivors who are several months or more post-stroke and in whom spasticity was not adequately managed in the early weeks and months.
When both are present, treatment needs to address both components. Treating the spasticity alone with botulinum toxin will reduce the neurological component of stiffness but will not address the structural shortening. Stretching and splinting alone will work against the structural shortening but will not address the ongoing neurological drive of the spasticity that is continually working to re-shorten the tissues.
A comprehensive approach that combines neurological management of spasticity with mechanical management of the structural component produces the best outcomes when both conditions are present simultaneously.
The most important principle in managing both conditions is to start early. Every week that a limb spends in a spastic, shortened position without adequate management is a week during which structural changes are accumulating. The earlier management begins, the less structural change has occurred and the more reversible the situation is.
Prolonged, low-load stretch applied consistently is the most fundamental intervention for preventing contracture in a limb affected by spasticity. The stretch needs to be held for meaningful periods, ideally 20 to 30 minutes or longer, to produce the sustained tissue lengthening needed to counteract the shortening driven by spasticity.
Brief stretching held for only a few seconds has minimal impact on muscle length. The tissues need time under sustained stretch to remodel. This is why positioning and splinting, which maintain stretch for hours at a time, are more effective for contracture prevention than manual stretching sessions alone.
Splints maintain the affected limb in a stretched, lengthened position for extended periods, providing the prolonged low-load stretch that is most effective for preventing and treating contracture. Resting hand splints, wrist extension splints, and elbow extension splints are commonly used depending on the pattern of spasticity and the joints at risk.
Serial casting is a more intensive form of prolonged stretch used when contracture has already developed. A series of casts are applied progressively, each one stretching the joint slightly further than the last, to gradually restore range of motion over a period of weeks. Serial casting is most effective for mild to moderate contracture and is typically performed by a specialist occupational therapist or physiotherapist.
Browse our range of upper limb contracture splints and positioning aids designed for stroke survivors.
Neuromuscular electrical stimulation applied to the antagonist muscles, those opposing the spastic muscle group, reduces spastic tone through reciprocal inhibition and helps maintain or restore range of motion. For a limb with flexor spasticity, stimulating the extensors with NMES helps reduce the flexor tone and maintain the joint in a more extended position.
NMES is most effective for the neurological component of stiffness. It addresses spasticity directly and indirectly helps prevent contracture by reducing the sustained muscle shortening driven by spastic tone. For electrode placement guidance, see our complete electrode placement guide for stroke recovery.
Botulinum toxin is most effective for spasticity when used before significant contracture has developed. By temporarily reducing the muscle tone in the spastic muscle, it creates a window of reduced resistance during which stretching, splinting, and active exercise can produce greater gains in range of motion than would be possible against the full spastic tone.
The timing of botulinum toxin injections relative to a stretching and splinting program is important. Injections work best when they are part of a coordinated plan that includes intensive physical management during the period of reduced tone following injection.
When contracture has already developed, the approach depends on its severity. Mild to moderate contracture responds to intensive prolonged stretching, serial casting, and splinting over a period of weeks to months. Significant improvements in range of motion are achievable even in established contracture when management is consistent and sustained.
Severe or long-standing contracture that has not responded to conservative management may require surgical intervention. Procedures including tendon lengthening, tendon release, and joint capsule release can restore range of motion when conservative approaches have been insufficient. Surgical intervention is typically followed by intensive rehabilitation and splinting to maintain the gains achieved.
For a comprehensive overview of spasticity treatment options across all stages of recovery, see our guide to post-stroke spasticity treatment.
Caregivers play a critical role in preventing contracture, particularly in the early weeks and months when the survivor may be dependent on others for positioning and daily care. The most important contributions caregivers can make are:
Correct positioning at all times. The affected limb should never be left in a flexed, shortened position for extended periods. When the survivor is sitting, the arm should be supported in a neutral or slightly extended position on a lap tray or armrest. When lying, the arm should be positioned in alignment rather than allowed to curl inward.
Gentle daily ranging. If the survivor cannot actively move the affected limb, a caregiver can perform passive range of motion exercises, gently moving the joint through its available range. This should be done gently and within comfortable limits, not pushed into pain. Ask the therapy team to demonstrate the correct technique.
Ensuring splints are worn as prescribed. If the therapy team has provided a splint, ensuring it is worn for the recommended hours each day is one of the most important contributions a caregiver can make to contracture prevention. Splints that sit unused in a drawer are not helping.
Reporting changes promptly. If the affected limb appears to be getting stiffer, if range of motion is decreasing, or if the survivor is reporting increasing pain, report it to the rehabilitation team promptly. Early intervention when contracture is beginning to develop is far more effective than waiting until it is well established.
Structural soft tissue changes can begin within one to two weeks of a limb being maintained in a shortened position. The rate of development depends on the severity of spasticity, the positioning of the limb, and the consistency of stretching and management. This is why positioning precautions should begin in the acute phase, even before significant spasticity has developed.
Early contracture can often be significantly reversed with consistent, intensive stretching and splinting over weeks to months. Established contracture is harder to fully reverse but can often be improved substantially with conservative management. Severe long-standing contracture may require surgical intervention to restore meaningful range of motion.
Botulinum toxin addresses the neurological component of stiffness and is most effective before significant contracture has developed. When contracture is present alongside spasticity, botulinum toxin can still be helpful by reducing the spastic component and making stretching and splinting more effective, but it will not address the structural shortening directly.
The simplest home assessment is to notice whether the stiffness feels the same when you move the limb slowly versus quickly. If it is worse with faster movement, spasticity is the primary component. If the resistance feels the same at any speed and there is a firm unyielding end-feel, contracture is likely present. A physiotherapist or occupational therapist can perform a more detailed clinical assessment to distinguish between the two and identify the most appropriate treatment.
Significant untreated contracture limits the range of motion available for rehabilitation and can restrict the functional use of the arm. However, contracture that is identified and treated appropriately does not have to be a permanent barrier to arm recovery. The key is early identification and consistent management. Survivors who address contracture proactively continue to make meaningful upper limb gains alongside their contracture management program.
Leave a Reply
You must be logged in to post a comment.